Phase I Study of Bortezomib and Romidepsin in Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Indolent B-Cell Lymphoma, or Peripheral T-Cell Lymphoma

Project: Research project

Project Details

StatusFinished
Effective start/end date8/1/11 → 7/31/13

Funding

  • Virginia Commonwealth University (PD300629-SC103981 // 5R21CA137823-02)
  • National Cancer Institute (PD300629-SC103981 // 5R21CA137823-02)